Compare Eaton Corporation plc (ETN) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Eaton Corporation plc trades at $428.84 (market cap $167.53B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: Eaton Corporation plc is far larger — about 2.9× Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.36%). Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| ETN | TAK | |
|---|---|---|
Market Cap | $167.53B | $58.16B |
Volume | 1,729,194 | 2,467,530 |
Sector | Industrials | Health |
52-Week High | $459.96 | $19.05 |
52-Week Low | $315.82 | $13.23 |
Typical Hold Time | 31 Days | 0 Days |
Enterprise Value | $188.16B | $86.04B |
Dividend Yield | 1.02% | 3.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $431.33, down 3.09% today but maintains strong analyst support with 28 buy ratings and a $502.38 consensus price target. The company demonstrates consistent earnings beats in recent quarters and benefits from strategic acquisitions in data center and aerospace markets. Technical indicators show a bullish moving average trend with neutral oscillators, while fundamentals reveal solid profitability with 12.75% net income margin and 19.71% ROE.
ETN presents a compelling investment case driven by AI data center demand and grid modernization trends, though elevated valuation multiples (P/E 43.92) warrant monitoring. Key risks include execution of recent acquisitions and competitive pressures in the electrical equipment sector. The stock offers 16% upside to consensus targets with strong institutional conviction supporting long-term growth prospects.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
